TAKE Solutions Ltd. [BSE: 532890 | NSE: TAKE], a leader in the Life Sciences (LS) and Supply Chain Management (SCM) domains, today, announced the financial results for the quarter ended June 30th, 2013. The company has posted revenues of INR 1,957 million for this quarter, which is a 1.8 percent decline in dollar terms over the previous quarter.
Commenting on TAKE Solutions’ performance, Srinivasan H.R., Vice-Chairman &Managing Director, TAKE Solutions said, “The performance during the quarter ended June 30, 2013 was as per our guidance for FY14. The demand remained soft during the quarter and is expected to remain subdued in the short term. We continue to work towards realigning our businesses and operations to make the company more profitable and creating value for our shareholders in the long term. Our focus is to be a 360 degree solution provider to the Life Sciences industry and to be a niche player in the Supply Chain Management domain”
About TAKE Solutions:
TAKE Solutions, Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suites include distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes.
TAKE has been recognized as a ‘Leader’ in IDC Health Insights’ “IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment”. TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit www.takesolutions.com
|
Figures in INR million
unless mentioned
|
Q1 FY14
|
Q-o-Q change (%)
|
|
Total Revenue
|
1,957
|
0.2%
|
|
EBITDA
|
353
|
-4.0%
|
|
Net Profit
|
132
|
-13.9%
|
|
Diluted Earnings Per Share (INR)
|
1.10
|
-14.0%
|
Commenting on TAKE Solutions’ performance, Srinivasan H.R., Vice-Chairman &Managing Director, TAKE Solutions said, “The performance during the quarter ended June 30, 2013 was as per our guidance for FY14. The demand remained soft during the quarter and is expected to remain subdued in the short term. We continue to work towards realigning our businesses and operations to make the company more profitable and creating value for our shareholders in the long term. Our focus is to be a 360 degree solution provider to the Life Sciences industry and to be a niche player in the Supply Chain Management domain”
About TAKE Solutions:
TAKE Solutions, Ltd. [BSE: 532890 | NSE: TAKE] is a leading global business technology company with domain expertise in Life Sciences (LS) and Supply Chain Management (SCM). TAKE provides cost-effective and comprehensive solutions for enterprises across diverse sectors including pharmaceuticals, high technology, consumer packaged goods, oil/gas, and automotive. TAKE’s SCM product suites include distinct technology with embedded IP that spans enterprise mobility, trading partner collaboration, and material tracking. In the LS domain, TAKE offers IP-based software and extensive knowledge-based solutions to enable efficient clinical, regulatory, safety and commercialization processes.
TAKE has been recognized as a ‘Leader’ in IDC Health Insights’ “IDC MarketScape: Worldwide Life Science Drug Safety Services 2013 Vendor Assessment”. TAKE’s global headquarters is in Chennai, India; its U.S. headquarters is located in Princeton, New Jersey. TAKE has a proven track record as a trusted partner in delivering world-class solutions to more than 400 customers worldwide. For more information, please visit www.takesolutions.com
